Skip to main content
Watch Insiders

Corporate insider profile

Howard Horn Insider Trades

Latest reported as Chief Financial Officer of Ultragenyx Pharmaceutical Inc. (RARE).

Purchase filings
0
Reported companies
1
Net open-market value
-$607,775.39
Latest transaction
Oct 15, 2026

Affiliated corporations

Reported company relationships

RARELatest reported

Ultragenyx Pharmaceutical Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 15, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale7,066$15.27$107,898
Aug 3, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,696$24.92$117,024
Jul 1, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,698$33.13$155,645
Jun 1, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,653$23.77$110,602
May 1, 2026Ultragenyx Pharmaceutical Inc. (RARE)Chief Financial OfficerSale4,683$24.90$116,607